Silencing Fas-associated phosphatase 1 expression enhances efficiency of chemotherapy for colon carcinoma with oxaliplatin
dc.creator | Zhi-Yu Xiao | |
dc.creator | Wei Wu | |
dc.creator | Navada Eagleton | |
dc.creator | Huan-Qing Chen | |
dc.creator | Jing Shao | |
dc.creator | Hong Teng | |
dc.creator | Tian-Hao Liu | |
dc.creator | Zhi-Min Jiang | |
dc.creator | He-Rui Yao | |
dc.date.accessioned | 2019-10-15T19:16:52Z | |
dc.date.available | 2019-10-15T19:16:52Z | |
dc.date.issued | 2010 | |
dc.identifier.issn | 1007-9327 | |
dc.identifier.issn | 2219-2840 | |
dc.identifier.uri | https://hdl.handle.net/1969.1/184856 | |
dc.format.extent | 1 | en |
dc.publisher | China National Journal of New Gastroenterology | |
dc.relation.ispartof | 1foldr Import 2019-10-08 Batch 14 | en |
dc.relation.uri | 10.3748/wjg.v16.i1.112 | en |
dc.title | Silencing Fas-associated phosphatase 1 expression enhances efficiency of chemotherapy for colon carcinoma with oxaliplatin | en |